These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32303624)

  • 21. P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma.
    Suh DH; Trinh HK; Liu JN; Pham le D; Park SM; Park HS; Shin YS
    J Cell Mol Med; 2016 Feb; 20(2):333-41. PubMed ID: 26612496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophil-derived chemokine (hCCL15/23, mCCL6) interacts with CCR1 to promote eosinophilic airway inflammation.
    Du X; Li F; Zhang C; Li N; Huang H; Shao Z; Zhang M; Zhan X; He Y; Ju Z; Li W; Chen Z; Ying S; Shen H
    Signal Transduct Target Ther; 2021 Feb; 6(1):91. PubMed ID: 33640900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-(1-7) Promotes Resolution of Eosinophilic Inflammation in an Experimental Model of Asthma.
    Magalhaes GS; Barroso LC; Reis AC; Rodrigues-Machado MG; Gregório JF; Motta-Santos D; Oliveira AC; Perez DA; Barcelos LS; Teixeira MM; Santos RAS; Pinho V; Campagnole-Santos MJ
    Front Immunol; 2018; 9():58. PubMed ID: 29434591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Icariside II attenuates eosinophils-induced airway inflammation and remodeling via inactivation of NF-κB and STAT3 in an asthma mouse model.
    Tian C; Gao F; Li X; Li Z
    Exp Mol Pathol; 2020 Apr; 113():104373. PubMed ID: 31917285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Eosinophils in Mouse Models of Asthma.
    Guthier HE; Zimmermann N
    Methods Mol Biol; 2022; 2506():211-222. PubMed ID: 35771474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin inhibition of eosinophil differentiation attenuates allergic airway inflammation in mice.
    Hua W; Liu H; Xia LX; Tian BP; Huang HQ; Chen ZY; Ju ZY; Li W; Chen ZH; Shen HH
    Respirology; 2015 Oct; 20(7):1055-65. PubMed ID: 26053964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophil expression of triggering receptor expressed on myeloid cells 1 (TREM-1) restricts type 2 lung inflammation.
    Bowen JL; Keck K; Baruah S; Nguyen KH; Thurman AL; Pezzulo AA; Klesney-Tait J
    J Leukoc Biol; 2024 Jul; 116(2):409-423. PubMed ID: 38547428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheb1 deletion in myeloid cells aggravates OVA-induced allergic inflammation in mice.
    Li K; Zhang Y; Liang KY; Xu S; Zhou XJ; Tan K; Lin J; Bai XC; Yang CL
    Sci Rep; 2017 Feb; 7():42655. PubMed ID: 28225024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice.
    Kobayashi T; Iijima K; Kita H
    J Immunol; 2003 Jun; 170(11):5756-63. PubMed ID: 12759459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SP600125 promotes resolution of allergic airway inflammation via TLR9 in an OVA-induced murine acute asthma model.
    Wu HM; Fang L; Shen QY; Liu RY
    Mol Immunol; 2015 Oct; 67(2 Pt B):311-6. PubMed ID: 26139014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma.
    Ochkur SI; Jacobsen EA; Protheroe CA; Biechele TL; Pero RS; McGarry MP; Wang H; O'Neill KR; Colbert DC; Colby TV; Shen H; Blackburn MR; Irvin CC; Lee JJ; Lee NA
    J Immunol; 2007 Jun; 178(12):7879-89. PubMed ID: 17548626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible factor-1α inhibition modulates airway hyperresponsiveness and nitric oxide levels in a BALB/c mouse model of asthma.
    Dewitz C; McEachern E; Shin S; Akong K; Nagle DG; Broide DH; Akuthota P; Crotty Alexander LE
    Clin Immunol; 2017 Mar; 176():94-99. PubMed ID: 28093362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precursor B Cells Increase in the Lung during Airway Allergic Inflammation: A Role for B Cell-Activating Factor.
    Samitas K; Malmhäll C; Rådinger M; Ramos-Ramirez P; Lu Y; Deák T; Semitekolou M; Gaga M; Sjöstrand M; Lötvall J; Bossios A
    PLoS One; 2016; 11(8):e0161161. PubMed ID: 27513955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal epithelial hypoxia inducible factor-1α expression regulates the response of the lung to experimental asthma.
    Greenwood KK; Proper SP; Saini Y; Bramble LA; Jackson-Humbles DN; Wagner JG; Harkema JR; LaPres JJ
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(5):L455-62. PubMed ID: 22180657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates poly (I:C)-induced airway inflammation in a murine model of asthma.
    Kim TB; Kim SY; Moon KA; Park CS; Jang MK; Yun ES; Cho YS; Moon HB; Lee KY
    Clin Exp Allergy; 2007 Nov; 37(11):1709-19. PubMed ID: 17877757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bcl-2 inhibitors reduce steroid-insensitive airway inflammation.
    Tian BP; Xia LX; Bao ZQ; Zhang H; Xu ZW; Mao YY; Cao C; Che LQ; Liu JK; Li W; Chen ZH; Ying S; Shen HH
    J Allergy Clin Immunol; 2017 Aug; 140(2):418-430. PubMed ID: 28043871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFκB.
    Xie T; Luo G; Zhang Y; Wang X; Wang X; Wu M; Li G
    Clin Exp Allergy; 2015 Dec; 45(12):1812-22. PubMed ID: 26245530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma.
    Tang W; Smith SG; Beaudin S; Dua B; Howie K; Gauvreau G; O'Byrne PM
    Int Arch Allergy Immunol; 2014; 163(1):5-10. PubMed ID: 24247484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma.
    Fu LQ; Li YL; Fu AK; Wu YP; Wang YY; Hu SL; Li WF
    Mol Med Rep; 2017 Oct; 16(4):4151-4158. PubMed ID: 28731127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma.
    Shimizu K; Konno S; Ozaki M; Umezawa K; Yamashita K; Todo S; Nishimura M
    Clin Exp Allergy; 2012 Aug; 42(8):1273-81. PubMed ID: 22805475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.